Latest News & Events

25 July 2020

Hummingbird Bioscience Scientific Advisory Board member Prof. John Connolly appointed as Chief Scientific Officer at the Parker Institute for Cancer Immunotherapy (Full Press Release - External Link

11 May 2020

Hummingbird Bioscience closes US$25M investment with Series B extension (Full Press Release)

20 February 2020

Hummingbird Bioscience announces agreement with Mycenax Biotech for production of anti-VISTA antibody HMBD-002 for cancer clinical trial (Full Press Release)

8 January 2020

Hummingbird Bioscience publishes preclinical data demonstrating efficacy of HMBD-001 in HER3 driven cancers (Full Press Release)

5 December 2019

Hummingbird Bioscience raises $19 Million in Series B financing to support expansion of its discovery pipeline and rapid development of its portfolio of targeted antibody therapeutics  (Full Press Release)

16 September 2019

Hummingbird Bioscience announces collaboration with Amgen to co-discover novel therapeutics using Hummingbird’s Rational Antibody Discovery Platform (Full Press Release)

8 August 2019

Cancer Research UK and Hummingbird Bioscience join forces to advance novel antibody drug into clinical trials (Full Press Release)

25 February 2019

Hummingbird Bioscience awarded $13.1 Million grant by the Cancer Prevention and Research Institute of Texas (CPRIT) (Full Press Release)

18 February 2019

Hummingbird Bioscience announces Nobel Laureate Dr. James Allison and Dr. Padmanee Sharma join its Scientific Advisory Board (Full Press Release)

9 November 2018

Hummingbird Bioscience to present data on HMBD-001-10D1 at the EORTC-NCI-AACR's 30th Annual Meeting (Full Press Release)

5 November 2018

Hummingbird Bioscience to present data on HMBD-002-V4 at the Society for Immunotherapy of Cancer (SITC)'s 33rd Annual Meeting (Full Press Release)

10 April 2018

Hummingbird Bioscience to present data on HMBD-002-V4 at the American Association for Cancer Research (AACR) 2018 Meeting (Full Press Release)

25 February 2018

Hummingbird Bioscience is featured on Biotech Strategy Blog discussing its CD47 bispecific pipeline (Full Press Release)

4 December 2017

Hummingbird Bioscience to present data on HMBD-004A at the 59th American Society of Hematology (ASH) Annual Meeting (Full Press Release)

3 May 2017

Hummingbird Bioscience announces it has closed a venture funding round of an undisclosed amount from Decheng Capital (Full Press Release)

3 Apr 2017

Hummingbird Bioscience presents latest progress on HMBD-001 and HMBD-002 at AACR in Washington DC

21 Mar 2017

Hummingbird Bioscience presents at Biopharma Asia in Singapore

19 Jan 2017 

Hummingbird Bioscience awarded SPRING Singapore TECS Grant to support continued development of Rational Antibody Development Platform

15 Nov 2016

Hummingbird Bioscience and University of Exeter are awarded UK MRC Proximity to Discovery Grant to collaborate on microfluidics based B-cell sequencing technologies

29 Mar 2016

Hummingbird Bioscience wins first place at the China Healthcare Investment Conference (CHIC) new venture competition in Shanghai

24 Nov 2015

Hummingbird Bioscience is featured in article: Hummingbird Bioscience - Intelligent drug development for cancers and beyond (Link)


21 Sept 2015

Hummingbird Bioscience CSO, Jerome Boyd-Kirkup, presents a poster "A Rational Antibody Development Platform for the Generation of Therapeutic Antibodies" at the Discovery on Target 2015 conference in Boston, USA

16 Sept 2015

Hummingbird Bioscience CEO, Piers Ingram, presents at Biotech Startup Day at BioPharm America, Boston, USA

10 Sept 2015

Hummingbird Bioscience is featured in BioCentury Innovations article: Epitope as Prologue: How Hummingbird develops antibodies against epitopes in natural conformation (Link)